RadNet, Inc. Announces Date of its Fourth Quarter 2025 Financial Results Conference Call
Rhea-AI Summary
RadNet (NASDAQ: RDNT) will host a conference call to discuss its fourth quarter 2025 financial results on Monday, March 2, 2026 at 7:30 a.m. PT / 10:30 a.m. ET. Investors can join by phone or via a simultaneous webcast.
Dial 844-826-3035 (U.S.) or 412-317-5195 (international). Webcast and archived replay details, including replay dial numbers and passcode 10206844, are provided for investor access.
Positive
- None.
Negative
- None.
News Market Reaction – RDNT
In the Feb 17 session, RDNT gained 2.21%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 03 | Indiana acquisition | Positive | -1.1% | Entry into Indiana via Northwest Radiology deal adding revenue and centers. |
| Jan 09 | Conference presentation | Neutral | -0.2% | J.P. Morgan Healthcare Conference presentation outlining business and footprint. |
| Jan 07 | Florida acquisition | Positive | +0.1% | Radiology Regional acquisition adding 13 centers and projected 2026 revenue. |
| Jan 07 | Leadership promotions | Positive | +0.1% | Expanded executive roles tied to record performance and strategic focus. |
| Dec 01 | AI product launch | Positive | -3.4% | DeepHealth Breast Suite AI platform launch for breast cancer screening. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news often produced muted or negative moves even on seemingly positive announcements, with acquisitions and product launches sometimes met by small gains or selloffs.
Over the last few months, RDNT has focused on expansion and leadership changes. Acquisitions in Southwest Florida and Indiana added centers and projected revenue, while executive promotions supported operational scaling. DeepHealth’s Breast Suite launch highlighted AI-driven innovation, and the company presented at a major healthcare conference. Despite generally positive business developments, 24-hour price reactions ranged from +0.06% to -3.36%, showing mixed market responses ahead of the newly announced Q4 2025 results call.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LOS ANGELES, Feb. 17, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its fourth quarter 2025 financial results on Monday, March 2, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Investors are invited to listen to RadNet’s conference call by dialing 844-826-3035. International callers can dial 412-317-5195. There will also be simultaneous and archived webcasts available at https://viavid.webcasts.com/starthere.jsp?ei=1753363&tp_key=503d78aa96 [viavid.webcasts.com]. An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international callers, and using the passcode 10206844.
About RadNet, Inc.
RadNet, Inc. is a leading national provider of freestanding, fixed-site diagnostic imaging services in the United States based on the number of locations and annual imaging revenue. RadNet has a network of owned and operated outpatient imaging centers in markets including Arizona, California, Delaware, Florida, Indiana, Maryland, New Jersey, New York and Texas. In addition, RadNet provides radiology information technology and artificial intelligence solutions marketed under the DeepHealth brand, teleradiology professional services and other related products and services to customers in the diagnostic imaging industry. Together with contracted radiologists, and inclusive of full-time and per diem employees and technologists, RadNet has over 12,000 team members. Learn more at www.radnet.com.
CONTACTS:
RadNet, Inc.
Mark Stolper
Executive Vice President and Chief Financial Officer
310-445-2800
